AGIOS PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Agios Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $45.8M, a 19.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $45.8M -$11.3M -19.8% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $48.8M -$11.1M -18.6% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $51.6M -$10.9M -17.5% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $54.4M -$10.7M -16.5% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $57.2M -$10.5M -15.6% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $59.9M -$10.3M -14.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $62.5M -$10.2M -14% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $65.1M -$10M -13.3% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $67.7M -$9.84M -12.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $70.2M -$9.69M -12.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $72.7M -$9.56M -11.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $75.1M -$9.54M -11.3% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $77.5M -$9.42M -10.8% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $79.9M -$9.31M -10.4% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $82.2M -$9.2M -10.1% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $84.7M -$8.98M -9.59% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $87M -$8.88M -9.27% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $89.2M -$9.29M -9.43% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $91.4M +$33.7M +58.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $93.6M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $95.8M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $98.5M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $57.8M Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.